Sugammadex Injection, Solution
Product Images NDC 66794-257

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 66794-257). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Piramal Critical Care Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

17 (2ml Carton)

Packaging label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) intravenous solution. The label indicates single-dose 2 mL vials, sold in a pack of 10, for prescription use only. Manufactured by Piramal Critical Care Inc., the label includes storage instructions, usage directions, and a barcode. The product is described as a clear to slightly yellow-brown sterile aqueous solution.*

FDA Label Image

17 (2ml Vial)

Packaging label for Sugammadex Injection showing strengths 200 mg/2 mL and 100 mg/mL. It specifies intravenous use only, a 2 mL single-dose vial, and includes the NDC 66794-256-02. The labeler is Piramal Critical Care Inc. The label also shows placeholders for lot number and expiration date.*

FDA Label Image

17 (5ml Vial)

Sugammadex Injection 500 mg/5 mL (100 mg/mL) intravenous solution label. The label includes dosing information, manufacturer Piramal Critical Care Inc., and instructions to discard unused portion and protect from light. The vial size is 5 mL single-dose. The label also shows lot and expiration placeholders, NDC code 66794-257-02, and barcode.*

FDA Label Image

17 (5ml Carton)

Packaging label for Sugammadex Injection 500 mg/5 mL (100 mg/mL) by Piramal Critical Care Inc. The label indicates it is for intravenous use only, sold as 10 single-dose 5 mL vials. Storage and usage instructions mention temperature control and protection from light. The label includes the NDC 66794-257-41 and a barcode.*

FDA Label Image

Chemical Structure (Bridion 01)

Chemical structure of sugammadex, showing its cyclic molecular arrangement with multiple sulfur atoms and carboxylate groups.*

FDA Label Image

Chemical Structure (Bridion 02)

Chemical structure of sugammadex showing a cyclic molecule with multiple hydroxyl groups, sulfur atoms, and sodium carboxylate groups. The ring contains interconnected sugar-like units with various substituents.*

FDA Label Image

Figure 1 (Bridion 03)

A Kaplan-Meier curve depicting the cumulative recovery rate over time in minutes for Sugammadex 2 mg/kg and Neostigmine 0.05 mg/kg after Rocuronium administration. The graph shows markedly faster recovery for Sugammadex compared to Neostigmine, with median recovery times of 1.4 minutes and 21.5 minutes respectively.*

FDA Label Image

Figure 2 (Bridion 04)

A Kaplan-Meier curve showing cumulative recovery rates over time for sugammadex 2 mg/kg versus neostigmine 0.05 mg/kg when used with vecuronium. The graph includes median recovery times with quartiles for both treatments and marks censored observations, comparing the time to recovery in minutes for the two drugs.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.